ロード中...
Randomized prospective phase III trial of (68)Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
BACKGROUND: Salvage radiotherapy (SRT) for prostate cancer (PCa) recurrence after prostatectomy offers long-term biochemical control in about 50–60% of patients. SRT is commonly initiated in patients with serum PSA levels < 1 ng/mL, a threshold at which standard-of-care imaging is insensitive for...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322287/ https://ncbi.nlm.nih.gov/pubmed/30616601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5200-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|